Walvax Biotechnology Co Ltd - Class A

SZSE:300142 (China)   Class A
Â¥ 9.96 (-1.29%) Sep 20
118.57
P/B:
1.68
Market Cap:
Â¥ 15.93B ($ 2.26B)
Enterprise V:
Â¥ 13.34B ($ 1.89B)
Volume:
13.80M
Avg Vol (2M):
16.64M
Trade In:
Volume:
13.80M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Walvax Biotechnology Co Ltd ( ) from 2011 to Sep 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Walvax Biotechnology stock (SZSE:300142) PE ratio as of Sep 22 2024 is 118.57. More Details

Walvax Biotechnology Co Ltd (SZSE:300142) PE Ratio (TTM) Chart

To

Walvax Biotechnology Co Ltd (SZSE:300142) PE Ratio (TTM) Historical Data

Total 1208
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Walvax Biotechnology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-22 118.6 2024-07-18 138.6
2024-09-20 118.6 2024-07-17 136.4
2024-09-19 120.1 2024-07-16 132.5
2024-09-18 117.9 2024-07-15 132.3
2024-09-13 118.9 2024-07-12 135.0
2024-09-12 120.6 2024-07-11 135.9
2024-09-11 121.2 2024-07-10 130.1
2024-09-10 119.6 2024-07-09 129.2
2024-09-09 119.6 2024-07-08 129.4
2024-09-06 120.7 2024-07-05 134.9
2024-09-05 122.3 2024-07-04 129.5
2024-09-04 120.1 2024-07-03 134.3
2024-09-03 122.3 2024-07-02 135.4
2024-09-02 120.7 2024-07-01 136.9
2024-08-30 123.7 2024-06-28 135.5
2024-08-29 125.8 2024-06-27 69.8
2024-08-28 125.2 2024-06-26 71.7
2024-08-27 121.5 2024-06-25 68.3
2024-08-26 122.1 2024-06-24 68.5
2024-08-23 121.0 2024-06-21 70.4
2024-08-22 120.8 2024-06-20 69.9
2024-08-21 123.7 2024-06-19 71.5
2024-08-20 127.3 2024-06-18 73.3
2024-08-19 130.4 2024-06-17 75.1
2024-08-16 132.5 2024-06-14 76.5
2024-08-15 132.4 2024-06-13 78.5
2024-08-14 131.7 2024-06-12 79.1
2024-08-13 136.1 2024-06-11 78.6
2024-08-12 139.9 2024-06-07 75.6
2024-08-09 134.4 2024-06-06 75.6
2024-08-08 138.7 2024-06-05 79.1
2024-08-07 138.7 2024-06-04 79.1
2024-08-06 140.4 2024-06-03 79.2
2024-08-05 135.5 2024-05-31 82.0
2024-08-02 136.2 2024-05-30 82.3
2024-08-01 135.6 2024-05-29 82.0
2024-07-31 137.9 2024-05-28 82.5
2024-07-30 129.8 2024-05-27 83.2
2024-07-29 130.7 2024-05-24 83.4
2024-07-26 133.2 2024-05-23 85.8
2024-07-25 133.3 2024-05-22 87.9
2024-07-24 130.2 2024-05-21 87.1
2024-07-23 131.9 2024-05-20 88.9
2024-07-22 136.8 2024-05-17 89.0
2024-07-19 139.3 2024-05-16 88.1

Walvax Biotechnology Co Ltd (SZSE:300142) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Walvax Biotechnology Co Ltd is engaged in research and development, production and sales of vaccine products.